Drug Type Small molecule drug |
Synonyms PRO VAP-1 inh + [1] |
Target |
Mechanism VAP-1 inhibitors(Amine oxidase, copper containing inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC21H20N6O |
InChIKeyJFFLQACNEMRJEZ-UHFFFAOYSA-N |
CAS Registry1628780-66-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoarthritis, Knee | Phase 2 | GB | 01 Sep 2013 | |
Inflammatory pain | Phase 2 | GB | - | |
Inflammatory pain | Phase 2 | HU | - | |
Inflammatory pain | Phase 2 | ES | - | |
Inflammatory pain | Phase 2 | PL | - | |
Pain | Phase 2 | - | - | |
Pain | Phase 2 | - | - | |
Inflammatory pain | Phase 1 | CZ | - |